Pediatric Oncology | Specialty

New Treatments in Acute Myeloid Leukemia

January 9th 2015

Role of Transplant in Acute Myeloid Leukemia

January 9th 2015

Therapeutic Targets in Acute Lymphoblastic Leukemia

January 9th 2015

CAR-Modified T Cell Therapy in ALL

January 9th 2015

Blinatumomab in Acute Lymphoblastic Leukemia

January 9th 2015

Minimum Residual Disease in ALL

January 9th 2015

Asparaginase in Acute Lymphoblastic Leukemia

January 9th 2015

Chemotherapy Regimens in Patients With ALL

January 9th 2015

TKIs in Philadelphia Chromosome-Positive ALL

January 9th 2015

Vincristine in Acute Lymphoblastic Leukemia

January 9th 2015

Identifying Transplant Candidates in ALL

January 9th 2015

Induction Therapy in Adult Ph-negative ALL

January 9th 2015

Introduction: Understanding ALL and Its Prognostic Factors

January 9th 2015

Aprepitant Yields Significant Benefits for the Prevention of CINV in Children

June 28th 2014

Aprepitant is significantly more effective than a comparator placebo-added regimen in preventing CINV in children, with benefits seen across all phases of treatment.

Dr. Litzow on Transplants in Patients with ALL

March 27th 2014

Mark R. Litzow, MD, chair, ECOG-ACRIN Leukemia Committee, professor of medicine, Division of Hematology, Mayo Clinic, discusses the role of transplant in patients with acute lymphoblastic leukemia

Eribulin Shows Promise in Pediatric Sarcomas

November 21st 2013

Eribulin has demonstrated a high level of antitumor activity that was equivalent or superior to vincristine across several sarcoma xenograft models, including at low dose levels, suggesting the drug may effectively treat pediatric patients with sarcoma.

Promoting Sleep in Children With Cancer

May 30th 2013

Rebecca Kronk, PhD, CRNP, MSN, writes about evidence recognizing sleep disturbances and fatigue as common occurrences in children with cancer during treatment, after treatment, and in long-term survivors.

Lessons on Patient Care Learned at Home

September 28th 2012

This fellow shares the insights he’s gained from his wife, a pediatric oncology nurse, and how they help in the care he provides.

Dr. Larsen Discusses Outcomes for AYA ALL Patients

June 7th 2012

Dr. Eric Larsen, from the Maine Children's Cancer Program, Discusses Outcomes for AYA Patients With Acute Lymphoblastic Leukemia

Providing Oncology Services in Impoverished Countries

April 15th 2012

Many of us training in the United States have encountered patients and their families from resource-limited regions of the world-families who have uprooted themselves for the chance to save the lives of their children diagnosed with cancer.